Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Small molecule shows potential for as a contraceptive for men

Aug. 22, 2012

Japanese approval for new dosage of Amaryl

Aug. 20, 2012

FDA approves sNDA for Tradjenta

Aug. 20, 2012

Research at Zafgen yields new candidate obesity drugs

Aug. 20, 2012

Unigene and Nordic Bioscience select preliminary lead compound for type 2 diabetes

Aug. 17, 2012

Fusion protein blocking BMP signaling stimulates bone formation

Aug. 16, 2012

FDA advisory committee schedules review of lomitapide NDA

Aug. 16, 2012

FDA accepts for filing Teva's NDA for new oral contraceptive

Aug. 14, 2012

Canadian university patents novel melanocortin MC4 receptor modulators

Aug. 14, 2012

Protalix BioTherapeutics to begin clinical testing of candidate Fabry's disease drug

Aug. 14, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...